Brahmachari: "Why should we worry about intellectual property protection for infectious diseases and diseases of the poor?"
Leading geneticist Samir Brahmachari explains why India should kickstart a new ’open source’ approach to drug discovery for diseases like TB.
Samir Brahmachari is one (…)
Q&A: Advocating open source drugs
T. V. Padma